Stability Testing in Pharmaceutical Development and Manufacture
Course
In Islington
Description
-
Type
Course
-
Location
Islington
-
Duration
2 Days
The purpose of this course is to give a comprehensive, integrated overview of pharmaceutical stability testing. Suitable for: People working in: Analytical Development. Analytical Chemistry. Stability Testing. Formulation Development. Regulatory Affairs. Pharmaceutical & Biopharmaceutical Production. Product Development. Technical Operations
Facilities
Location
Start date
Start date
Reviews
Teachers and trainers (1)
Michael Gamlen
Course Speaker
Michael is managing director of Pharmaceutical Development Services Limited, a Guildford UK-based technical consultancy. Michael has over 30 years experience of tablet development. Awarded a first class honours degree in pharmacy, specialising in pharmaceutical engineering. He studied for a PhD at Nottingham University. He was head of tablet development at the The Wellcome Foundation for 15 years, and has since worked for Vanguard Medica Limited and as a consultant.
Course programme
Overview
- Why is stability required?
- What are the requirements for Clinical Trials, new products, and existing products?
- How can you ensure that your programme meets worldwide requirements?
It will include:
- A comprehensive review of ICH guidance
- Pitfalls in stability testing
- Outsourcing—costs and benefits
- New approaches to stability testing including ASAP
- Stability Testing and QbD
- Workshops for attendees to present and discuss their own stability testing issues with the group
Additional Resources
Online access to comprehensive publications including all relevant guidance will be provided as well as colour copies of all presentations and case studies.
Numbers in our courses are limited to ensure that participants have the opportunity for thorough discussion of the issues to be covered and individual attention from our top-ranked Speakers
Course Programme
DAY 1
Stability testing in the new world of QbD
- Stability testing and the Lifecycle approach to product development
- Formulation development
- Manufacturing
History of stability testing
- How we got to where we are
- Role of ICH
Overview of ICH guidance relevant to stability testing
- Stability testing
- Impurities
- Specifications
LUNCH
Detailed review of ICH stability testing documents ICH Q1A
Defining and setting specifications – ICH Guidance Q6A
- Preclinical
- Clinical trial
- Product registration
ASAP – a new approach to stability testing the drug product
Question and Answer session
DAY 2
Matrixing and bracketing pitfalls and purpose – ICH guidance Q1D
Quality systems issues
- Safeguarding data quality
Shelf lives and expiration dating – interpreting and using data.
- Applying ICH Guidance Q1E
Out spec and out of trend data. Assessing outliers.
LUNCH
Photostability testing of new dosage forms ICH Q1B
- History, purpose and implementation of guidance
Applications/case studies
- Case 1 syrup preformulation paper
- Case 2 tablet formulation selection
- Case 3 Definitive testing
- Case 4 Busulfan liquid
Workshop and examples based on delegate’s interests
Group discussion, problem solving and consultancy.
Stability Testing in Pharmaceutical Development and Manufacture